dimenhydrinate + phenylephrine hydrochloride + caffeine Capsules 20 mg + 10 mg + 25 mg
Dossier type
CTD
Dossier status
Ready to file
Country of origin
Switzerland
GMP approvals
WHO
Manufacturer #21052
The CTD dossier owner and manufacturer is committed to value as the basis of building and, above all, maintaining trust in a period during which technologies and trends are constantly changing at an ever-increasing speed. More than 30 of the high-quality products are manufactured in compliance with Good Manufacturing Practice (GMP) standards according to the World Health Organisation's (WHO) guidelines and are distributed by the network of highly competent medical representatives in more than 50 markets.
Manufacturer usually replies in nan days
Dimenhydrinate is a pharmaceutical drug that is used to treat insomnia, vertigo and nausea. As a standalone drug, it is primarily marketed as dimenhydrinate tablets but is also available in liquid and suppository form. Depending on the formulation, it is can be administered orally, or by way of either intravenous or intramuscular injection.
Dimenhydrinate is also commonly used as an ingredient in combination drugs, along with substances such as cinnarizine, pyridoxine, paracetamol, and others. Major suppliers of trade name dimenhydrinate medications include Pfizer, Sandoz, and Teva. On the other hand, suppliers Fresenius Kabi, Mylan are few of the distributors of generic versions of the drug.
Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform.